Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country

List of Tables

The colorectal cancer market in Europe is expected to grow from US$ 4,627.82 million in 2022 to US$ 5,819.96 million by 2028; it is estimated to grow at a CAGR of 2.9% from 2022 to 2028.

The market for colorectal cancer is ascribed to frequent diagnostic tests and new drug launches. Many major market players are involved in manufacturing a wide range of drugs and diagnostic tests that help in reducing the burden of colorectal cancer. For instance, in June 2021, Bristol Myers Squibb announced the approval of Opdivo plus Yervoy by the European Commission (EC) for the treatment of adult patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer. Also, in September 2019, Lupin, an Indian pharmaceutical company, partnered with Boehringer Ingelheim, a German-based pharmaceutical company, for the development of cancer drugs. The companies collaborated to develop and commercialize a drug based on the MEK inhibitor. The molecule is likely to target specific cancer cells and treat patients suffering from stomach and skin cancer. In June 2019, Pfizer, Inc. launched ZIRABEV, a biosimilar to Avastin that helps in the treatment of five cancers, including colorectal cancer. Thus, the constant developments and new product launches in colorectal cancer diagnostics and therapeutics are driving the colorectal cancer market growth in Europe.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe colorectal cancer market at a substantial CAGR during the forecast period.

Europe Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)

Europe Colorectal Cancer Market Segmentation

The Europe colorectal cancer market is segmented into modality, end user, and country. Based on modality, the Europe colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. In 2022, the diagnosis type segment held the largest market share and is expected to register the highest CAGR during the forecast period. Based on end user, the Europe colorectal cancer market is bifurcated into hospitals and diagnostic & research laboratories. In 2022, the hospitals segment held a larger market share. Based on country, the Europe colorectal cancer market is segmented into France, Germany, Italy, Spain, the UK, and the Rest of Europe. The Rest of Europe held the largest market share in 2022.

Abbott, Amgen Inc., Bruker Corporation, EDP Biotech Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics, and VolitionRx Limited are among the leading companies operating in the Europe colorectal cancer market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe colorectal cancer market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the colorectal cancer market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: TIPRE00009258

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Colorectal Cancer Market - By Modality
- 1.3.2 Europe Colorectal Cancer Market - By End User
- 1.3.3 Europe Colorectal Cancer Market - By Country

2. Europe Colorectal Cancer Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Colorectal Cancer- Market Landscape

4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion

5. Europe Colorectal Cancer Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Colorectal Cancer
- 5.1.2 New Product Launches
- 5.1.3 Benefits Offered by Generic Drugs
5.2 Market Restraints
- 5.2.1 Pricing Pressure on Drug Manufacturers
5.3 Future Trends
- 5.3.1 Shift Toward Personalized Medicine
5.4 Impact Analysis

6. Europe Colorectal Cancer Market- Europe Analysis

6.1 Europe Colorectal Cancer Market Revenue Forecast and Analysis

7. Europe Colorectal Cancer Market Analysis - By Modality

7.1 Overview
7.2 Europe Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%)
7.3 Diagnosis Type
- 7.3.1 Overview
- 7.3.2 Diagnosis Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.3 Immunohistochemistry
  - 7.3.3.1 Overview
  - 7.3.3.2 Immunohistochemistry: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.4 Stool Test
  - 7.3.4.1 Overview
  - 7.3.4.2 Stool Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.5 Flexible Sigmoidoscopy
  - 7.3.5.1 Overview
  - 7.3.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.6 Colonoscopy
  - 7.3.6.1 Overview
  - 7.3.6.2 Colonoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.7 CEA Test
  - 7.3.7.1 Overview
  - 7.3.7.2 CEA Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.8 Other Test
  - 7.3.8.1 Overview
  - 7.3.8.2 Other Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Therapy Type
- 7.4.1 Overview
- 7.4.2 Europe Therapy Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.3 Chemotherapy
  - 7.4.3.1 Overview
  - 7.4.3.2 Chemotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.3.3 Alkylating Agent
    - 7.4.3.3.1 Overview
    - 7.4.3.3.2 Alkylating Agent: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.3.4 Antimetabolites
    - 7.4.3.4.1 Antimetabolites: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.3.5 Others
    - 7.4.3.5.1 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.4 Immunotherapy
  - 7.4.4.1 Overview
  - 7.4.4.2 Immunotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.4.3 Panitumumab
    - 7.4.4.3.1 Overview
    - 7.4.4.3.2 Panitumumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.4.4 Cetuximab
    - 7.4.4.4.1 Overview
    - 7.4.4.4.2 Cetuximab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.4.5 Bevacizumab
    - 7.4.4.5.1 Overview
    - 7.4.4.5.2 Bevacizumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.4.6 Others
    - 7.4.4.6.1 Overview
    - 7.4.4.6.2 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.5 Chemoprotectant
  - 7.4.5.1 Overview
  - 7.4.5.2 Chemoprotectant: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.6 Others
  - 7.4.6.1 Overview
  - 7.4.6.2 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Imaging Type
- 7.5.1 Overview
- 7.5.2 Europe Imaging Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5.3 Computed Tomography (CT)
  - 7.5.3.1 Overview
  - 7.5.3.2 Computed Tomography (CT) : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5.4 Magnetic Resonance Imaging (MRI)
  - 7.5.4.1 Overview
  - 7.5.4.2 Magnetic Resonance Imaging (MRI) : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5.5 Others
  - 7.5.5.1 Overview
  - 7.5.5.2 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Colorectal Cancer Market Revenue and Forecast To 2028 - By End User

8.1 Overview
8.2 Europe Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic and Research Laboratories
- 8.4.1 Overview
- 8.4.2 Diagnostic and Research Laboratories: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Colorectal Cancer Market Revenue and Forecast to 2028 - Country Analysis

9.1 Overview
- 9.1.1 Europe: Colorectal Cancer Market, by Country, 2022 & 2028 (%)
  - 9.1.1.1 Germany: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.1.1 Germany: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.1.2 Germany: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
    - 9.1.1.1.2.1 Germany: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
    - 9.1.1.1.2.2 Germany: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
    - 9.1.1.1.2.2.1 Germany: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
    - 9.1.1.1.2.2.2 Germany: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
    - 9.1.1.1.2.3 Germany: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
    - 9.1.1.1.3 Germany: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  - 9.1.1.2 France: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.2.1 France: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.2.2 France: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
    - 9.1.1.2.2.1 France: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
    - 9.1.1.2.2.2 France: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
    - 9.1.1.2.2.2.1 France: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
    - 9.1.1.2.2.2.2 France: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
    - 9.1.1.2.2.3 France: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
    - 9.1.1.2.3 France: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  - 9.1.1.3 UK: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.3.1 UK: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.3.2 UK: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
    - 9.1.1.3.2.1 UK: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
    - 9.1.1.3.2.2 UK: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
    - 9.1.1.3.2.2.1 UK: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
    - 9.1.1.3.2.2.2 UK: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
    - 9.1.1.3.2.3 UK: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
    - 9.1.1.3.3 UK: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  - 9.1.1.4 Italy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.4.1 Italy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.4.2 Italy: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
    - 9.1.1.4.2.1 Italy: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
    - 9.1.1.4.2.2 Italy: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
    - 9.1.1.4.2.2.1 Italy: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
    - 9.1.1.4.2.2.2 Italy: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
    - 9.1.1.4.2.3 Italy: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
    - 9.1.1.4.3 Italy: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  - 9.1.1.5 Spain: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.5.1 Spain: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.5.2 Spain: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
    - 9.1.1.5.2.1 Spain: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
    - 9.1.1.5.2.2 Spain: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
    - 9.1.1.5.2.2.1 Spain: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
    - 9.1.1.5.2.2.2 Spain: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
    - 9.1.1.5.2.2 Spain: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
    - 9.1.1.5.3 Spain: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  - 9.1.1.6 Rest of Europe: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.6.1 Rest of Europe: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.6.2 Rest of Europe: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
    - 9.1.1.6.2.1 Rest of Europe: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
    - 9.1.1.6.2.2 Rest of Europe: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
    - 9.1.1.6.2.2.1 Rest of Europe: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
    - 9.1.1.6.2.2.2 Rest of Europe: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
    - 9.1.1.6.2.3 Rest of Europe: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
    - 9.1.1.6.3 Rest of Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)

10. Global Colorectal Cancer Market - Industry Landscape

10.1 Overview
10.2 Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.3 Organic Developments
- 10.3.1 Overview
- 10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.4 Inorganic Developments
- 10.4.1 Overview
- 10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028

11. Company Profiles

11.1 Epigenomics AG
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Novigenix SA
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Abbott
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Amgen Inc.
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 F. HOFFMANN-LA ROCHE LTD.
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Bruker Corporation
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Quest Diagnostics Incorporated
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 EDP Biotech Corporation
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Volitionrx Limited
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms